Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
GeneDx Holdings Corp.

GeneDx Holdings Corp. (WGS) Stock Overview

Explore GeneDx Holdings Corp.’s financial performance, market position, analyst ratings, and future outlook.

WGS●NASDAQ
HealthcareMedical - Healthcare Information Services
$59.10
$4.28(6.75%)
U.S. Market opens in 63h 27m

GeneDx Holdings Corp. (WGS)

Meyka AI Score

Z

Key Financials

Market Cap1.8B
P/E Ratio-22.66
EPS (TTM)$0.85
ROE-0.28%
Fundamental Analysis

AI Price Forecasts

1 Month$104.57
3 Months$63.36
1 Year Target$134.04

WGS Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of GeneDx Holdings Corp. (NASDAQ: WGS) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, GeneDx Holdings Corp.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of WGS on the NASDAQ shows an RSI of 45.67, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $134.04 for the NASDAQ listing.

Key metrics behind GeneDx Holdings Corp.'s NASDAQ-traded stock include a P/E ratio of -22.66 and a market capitalization of 1.8B. Combined with our AI analysis, these give both institutional and retail investors a clear view of WGS on the NASDAQ.

Price Performance (NASDAQ: WGS)

1-Day Change
-6.75%
5-Day Change
-1.09%
1-Month Change
-6.99%
3-Month Change
-13.76%
6-Month Change
-41.69%
Year-to-Date (YTD) Change
-54.56%
1-Year Change
-27.44%
3-Year Change
659.64%
5-Year Change
-84.32%
All-Time (Max) Change
-81.73%

Contact Information

http://www.genedx.com
800 298 6470
North Tower, Stamford, CT, 06902

Company Facts

13,000 Employees
IPO DateNov 4, 2020
CountryUS
Actively Trading

Frequently Asked Questions